We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.51B
AUM Growth
+$540M
Cap. Flow
-$18.6M
Cap. Flow %
-0.34%
Top 10 Hldgs %
46.25%
Holding
691
New
31
Increased
112
Reduced
426
Closed
60

Top Buys

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$33.3M
2
BE icon
Bloom Energy
BE
+$30.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25M
4
SNDK
Sandisk
SNDK
+$23.5M
5
NBIS
Nebius Group N.V.
NBIS
+$22.4M

Top Sells

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$36.2M
2
CLS icon
Celestica
CLS
+$21.9M
3
WMT icon
Walmart Inc
WMT
+$21.5M
4
UNH icon
UnitedHealth
UNH
+$20.7M
5
YUMC icon
Yum China
YUMC
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 48.98%
2 Communication Services 15.81%
3 Consumer Discretionary 13.07%
4 Healthcare 6.06%
5 Consumer Staples 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTL icon
526
Castle Biosciences
CSTL
$742M
$14.2K ﹤0.01%
624
-92
-13% -$1.87K
TERN
527
DELISTED
Terns Pharmaceuticals
TERN
$14.1K ﹤0.01%
1,883
-291
-13% -$1.86K
SIGA icon
528
SIGA Technologies
SIGA
$240M
$14K ﹤0.01%
1,529
-299
-16% -$2.39K
KROS icon
529
Keros Therapeutics
KROS
$197M
$13.8K ﹤0.01%
870
-166
-16% -$2.45K
ARVN icon
530
Arvinas
ARVN
$530M
$13.5K ﹤0.01%
1,580
-179
-10% -$1.36K
KALV
531
DELISTED
KalVista Pharmaceuticals
KALV
$13.2K ﹤0.01%
1,083
-164
-13% -$2.27K
ERAS icon
532
Erasca
ERAS
$6.15B
$13.2K ﹤0.01%
6,033
-1,207
-17% -$1.92K
SVRA icon
533
Savara
SVRA
$1.08B
$13.1K ﹤0.01%
3,667
-728
-17% -$2.15K
EVRG icon
534
Evergy
EVRG
$19.4B
$13K ﹤0.01%
171
– –
NI icon
535
NiSource
NI
$21.5B
$12.6K ﹤0.01%
290
– –
PSNL icon
536
Personalis
PSNL
$1.25B
$12.4K ﹤0.01%
1,908
+99
+5% +$563
AEE icon
537
Ameren
AEE
$30.4B
$12.3K ﹤0.01%
118
– –
DTE icon
538
DTE Energy
DTE
$29.9B
$12.3K ﹤0.01%
87
– –
DHC
539
Diversified Healthcare Trust
DHC
$2.15B
$12.1K ﹤0.01%
2,738
-275
-9% -$1.05K
CRVS icon
540
Corvus Pharmaceuticals
CRVS
$1.1B
$11.8K ﹤0.01%
1,603
+9
+0.6% +$46
SAFE
541
Safehold
SAFE
$1.17B
$11.8K ﹤0.01%
761
-71
-9% -$1.1K
UPXI icon
542
Upexi
UPXI
$58.3M
$11.6K ﹤0.01%
+2,006
New +$12.2K
ESPR
543
DELISTED
Esperion Therapeutics
ESPR
$11.5K ﹤0.01%
4,338
-707
-14% -$1.37K
ZVRA icon
544
Zevra Therapeutics
ZVRA
$578M
$11.5K ﹤0.01%
1,208
-159
-12% -$1.59K
NXRT
545
NexPoint Residential Trust
NXRT
$689M
$11.5K ﹤0.01%
356
-59
-14% -$1.94K
CMPS
546
Compass Pathways
CMPS
$1.47B
$11.3K ﹤0.01%
1,973
+712
+56% +$3.2K
PRTA icon
547
Prothena Corp
PRTA
$448M
$11.3K ﹤0.01%
1,155
-222
-16% -$1.71K
RIGL icon
548
Rigel Pharmaceuticals
RIGL
$723M
$10.9K ﹤0.01%
384
-67
-15% -$2K
ARCT icon
549
Arcturus Therapeutics
ARCT
$165M
$10.8K ﹤0.01%
585
-108
-16% -$1.74K
LKFT
550
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$10.6K ﹤0.01%
305
-52
-15% -$1.66K
20 21
22
23 24

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q3 2025 Portfolio in Review

As of Q3 2025, GF Fund Management held 691 positions worth $5.51B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q3 2025 filing shows 31 new, 112 increased, 426 reduced and 60 closed positions. Its largest new stake was Bloom Energy: 648,856 shares worth $54.9M. The largest sale was British American Tobacco, an estimated $36.2M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 46% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q3 2025 buy was Bloom Energy: 648,856 shares worth $54.9M.
  • GF Fund Management added most to Lumentum in Q3 2025, an estimated $33.3M increase.
  • GF Fund Management's biggest Q3 2025 reduction was British American Tobacco, cutting an estimated $36.2M.
  • GF Fund Management fully exited Yum China in Q3 2025, selling an estimated $14.8M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.51B portfolio in Q3 2025.
  • GF Fund Management opened 31 new positions and closed 60 in Q3 2025.
  • GF Fund Management's portfolio value rose 11% quarter-over-quarter to $5.51B.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.